M42 Partners With 10X Health And REVIV Global To Launch Innovative 10XREVIV For Precision Health

M42, a leader in global health technology, has formed a strategic alliance with 10X Health from the USA and REVIV Global from the UK. This collaboration aims to introduce 10XREVIV, a venture focused on revolutionising precision health, nutrition, and longevity. The initiative will bring an innovative Precision Nutrition System to the Middle East, combining genetic insights and nutritional science through AI for personalised health optimisation.

Central to this partnership is the 10X Precision Nutrition System. Developed over more than ten years by top biotechnologists and data scientists, this patented platform uses proprietary AI algorithms. It analyses up to 20 million genetic variations with 99.97% accuracy, integrating DNA, blood chemistry, and lifestyle inputs to create a unique biological blueprint for each individual.

The system generates a secure digital health report of over 400 pages. This report provides actionable insights into nutrient absorption, metabolic efficiency, inflammation, immune function, cardiovascular health, and longevity pathways. These insights are then translated into precision-based interventions like supplements and weight management solutions tailored to individual needs.

10XREVIV offers various clinically validated interventions based on these insights. These include 10X Precision Supplements with up to 22 micronutrients optimised for genetic compatibility and bioavailability. Additionally, there are targeted weight management solutions that modulate carbohydrates and fats according to individual metabolic profiles. Precision IV Therapy protocols provide bespoke micronutrient infusions through certified medical facilities.

The partnership will also establish a Precision Longevity flagship clinic and conduct a trial on IV nutrition's impact on Type 2 Diabetes. A training curriculum will be launched for medical practitioners to interpret genetic data in clinical settings, enhancing patient outcomes.

Expert Insights

Albarah El Khani of M42 stated their commitment to redefining healthcare delivery by integrating AI and life sciences. "Our partnership with 10X Health and REVIV Global represents a significant step toward precision-based care," El Khani said. Brandon Dawson of 10X Health highlighted the expansion of their proprietary system into advanced healthcare ecosystems through this collaboration.

Sarah Lomas from REVIV Global expressed excitement about combining cutting-edge genetics with world-class clinical delivery in the Middle East. "This alliance elevates our vision by combining cutting-edge genetics, AI-driven nutrition and world-class clinical delivery," Lomas commented.

This collaboration marks a new benchmark in human optimisation where science meets technology for enhanced healthcare outcomes.

With inputs from WAM